DPTX3186, an orally administered small molecule condensate modulator (c-mod) inhibiting the oncogenic function of beta catenin, as a potential therapeutic agent for treatment of Wnt-driven cancers.
For research use only. We do not sell to patients.
| Name | DPTX-3186 |
|---|---|
| Iupac Chemical Name | (1,3-Oxazol-2-yl)methyl [5-[(1R)-1-(6-methoxypyridin-3-yl)ethyl]-1,3-thiazol-2-yl]carbamate |
| Synonyms | DPTX 3186 ; DPTX-3186 ; DPTX3186 |
| Molecular Formula | C16H16N4O4S |
| Molecular Weight | 360.09 |
| Smile | O=C(OCC1=NC=CO1)NC2=NC=C([C@@H](C3=CC=C(OC)N=C3)C)S2 |
| InChiKey | DWGSFRBOLWGIIE-SNVBAGLBSA-N |
| InChi | InChI=1S/C16H16N4O4S/c1-10(11-3-4-13(22-2)18-7-11)12-8-19-15(25-12)20-16(21)24-9-14-17-5-6-23-14/h3-8,10H,9H2,1-2H3,(H,19,20,21)/t10-/m1/s1 |
| CAS Number | |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | ≧98.0% |
| Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
| Solubility | Soluble in DMSO (DMSO : ≥ 100 mg/mL) |
| Handling | Refer to MSDS |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| HS Code | 2934200090 |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |